https://scholars.lib.ntu.edu.tw/handle/123456789/460300
標題: | Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial | 作者: | Lee T.-H Lin Y.-H Seow K.-M Hwang J.-L Tzeng C.-R YU-SHIH YANG |
公開日期: | 2008 | 卷: | 90 | 期: | 1 | 起(迄)頁: | 113-120 | 來源出版物: | Fertility and Sterility | 摘要: | Objective: To evaluate the effectiveness of a GnRH antagonist in preventing premature LH surge under a letrozole and gonadotropin protocol. Design: Prospective, randomized clinical trial. Setting: A teaching hospital and tertiary medical center. Patient(s): Sixty-one patients were randomly assigned into two letrozole and gonadotropin-treated groups. These were distinguished by the absence (group I) or presence (group II) of supplementation with 0.25 mg of cetrorelix. Intervention(s): Controlled ovarian stimulation with letrozole and gonadotropins, cetrorelix and intrauterine insemination. Main Outcome Measure(s): Rate of premature LH surge. Result(s): Compared with group I, the rate of premature LH surge was statistically significantly lower for group II (43.4% [13/30] vs. 19.4% [6/31]), but the amount of gonadotropins used was statistically significantly higher (817.5 ± 28.5 vs. 907.5 ± 27.3 IU). Patients with premature LH surge had a statistically significantly lower pregnancy rate (21.4% [9/42] vs. 0 [0/18]) relative to their unaffected counterparts. Conclusion(s): A flexible protocol of 0.25 mg of cetrorelix for IUI cycles appears to suppress the rate of premature LH surge during ovarian stimulation with letrozole and gonadotropins. However, the incidence of premature LH surge remains too high, and modification will be necessary before the application of cetrorelix to IVF treatment. ? 2008 American Society for Reproductive Medicine. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/460300 | ISSN: | 0015-0282 | DOI: | 10.1016/j.fertnstert.2007.06.029 | SDG/關鍵字: | cetrorelix; chorionic gonadotropin; gonadorelin antagonist; gonadotropin derivative; letrozole; luteinizing hormone; recombinant chorionic gonadotropin; recombinant follitropin; adult; article; cell stimulation; clinical trial; controlled clinical trial; controlled study; dose response; drug efficacy; female; female infertility; fertilization in vitro; human; intrauterine insemination; major clinical study; ovary cell culture; pregnancy rate; priority journal; prospective study; randomized controlled trial; statistical significance; university hospital; Adult; Aromatase Inhibitors; Chorionic Gonadotropin; Drug Therapy, Combination; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Hormone Antagonists; Humans; Infertility; Luteinizing Hormone; Nitriles; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Recombinant Proteins; Taiwan; Treatment Outcome; Triazoles; Up-Regulation |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。